Houston Exponential names winners of inaugural innovation awards

And the winner is...

Here's who won big for Houston innovation. Photos courtesy

In a virtual awards program, Houston Exponential has revealed the winners of the inaugural Listies awards.

The Listies, brought to you by Houston Exponential in partnership with InnovationMap, named the winning companies and people across 12 awards on November 20 at 3 pm as a part of Impact Hub's annual The Houston Innovation Summit (THIS).

Nominations were open until Friday, November 6, and then a group of judges made up of members of the Houston innovation ecosystem reviewed the submissions to settle on the 38 finalists. Click here to see the finalists.

Here's who took home the big wins.

SDO Superstar: MassChallenge Texas

Photo courtesy of MassChallenge

A startup development organization can be an accelerator program, an incubator, or a coworking space — and organizations falling into all three of these sectors were nominated for this category. MassChallenge Texas, which has been running its non-equity, general accelerator program in Houston for two years, stood out to judges to take the win for the SDO Superstar category.

Individual Contributor: Slawek Omylski of SecurityGate

Photo via LinkedIn

The individual contributor award was meant to find and recognize a non-founder who was essential to the success of a Houston startup, and that's exactly how SecurityGate's team sees Slawek Omylski, director of engineering. Not only has he been essential from the start over three years ago when he joined as employee No. 4, but Omylski, when unexpectedly having to move back home to Italy, never missed a single meeting or tech deployment despite being an ocean away from the rest of his team. Known as "Suave" by his teammates, his nominators say Omylski is usually the first to arrive at the office and the last to leave.

Civic Innovation: Annapurna Solutions

Image viaannapurnasolutions.org

Everyone knows that the key to sustainability is reducing, reusing, and recycling, but the fact of the matter is no one has quite perfected recycling. Houston-based Annapurna Solutions is stepping in to help. The company provides innovative technology solutions to address waste and recycling challenges, helping to make cities smart and sustainable — like the company's ReciklApp.

Welcome to Houston: Greentown Labs

Photo via greentownlabs.com

Greentown Labs is a startup development organization, but it's are also a startup itself, but when it opens its doors in Houston in the spring, the organization isn't starting from scratch. After years of working with over 200 climatech companies in the Boston area, Greentown's expansion into Houston means incubating Houston energy tech companies and furthering the conversation and activation within the energy transition.

Investor of the Year: Integr8d Capital

Photo via TMC.edu

John "J.R." Reale has been a well respected mentor, entrepreneur, and investor in Houston for years. His firm Integr8d Capital has invested in several Houston companies, including Liongard from seed stage to series A and series B. Reale is also the entrepreneur in residence for the TMC Innovation Institute.

Corporate Innovator: Houston Methodist

Courtesy of Methodist Hospital/Facebook

Houston Methodist and its Center for Innovation led by Roberta Schwartz is leading health tech innovation in Houston. In January, the hospital opened its Technology Hub, 3,500-square-foot space renovated from a former 18-room patient wing to showcase and test new digital health technologies like virtual reality, ambient listening, wearables, and more. Additionally, the hub helped with the training of dozens of doctors with the rise of telemedicine during COVID-19.

Outstanding Leadership: Grace Rodriguez

Photo courtesy of Grace Rodriguez

Grace Rodriguez's career spans industry and time, but her leadership has been consistent throughout. She currently serves Impact Hub Houston as CEO and executive director. Her nominator calls her an inspiration and someone who "shows up," clearly loving everything she does and is responsible. During COVID-19, she's gone above and beyond to provide resources and information to everyone who needs it, including launching a fund to help pay for meals for health care workers and first responders. The LIFE Fund raised over $20,000.

COVID Phoenix: Luminare

Image via luminaremed.com

Originally founded by Dr. Sarma Velamuri to treat and fight sepsis, Luminare took its sepsis platform and pivoted it to created a COVID self-assessment and testing tool. Their digital platform directed 5.5 million people to COVID-19 testing sites in just 21 days, according to its nomination. The tool was used by Harris County and several other entities.

DEI Champion: Maria Maso

Photo courtesy of Nijalon Dunn

Maria Maso is looking out for minorities when it comes to investment. As the founder and CEO of the Business Angel Minority Association (baMa) — an Angel Association aimed at bridging minority-founded startups with accesses to capital — Maria has been a champion for diversity. She also has helped to educate and activate 40 diverse investors through baMa's Diversity Investor Academy, according to her nomination.

Mentor of the Year: Landi Spearman

Photo via LinkedIn

Landi Spearman's approach to mentorship, according to her nominee, is to mentor the full person — from professional to personal life — through Organized SHIFT, which focuses on helping highly productive leaders, individuals and organizations in their quest to sustain positive growth internally and externally. She also supports entrepreneurs though The Ion, Station Houston, General Assembly, the National Urban League, Power to Fly, Black Women in Science and Engineering, the Greater Houston Partnership, the Greater Houston Black Chamber, Pink Petro, and more.

People's Choice and Soonicorn: Liongard

Photos via LinkedIn

People's Choice was based off how many nominations the startups received, and Liongard was a clear winner. The company, which also won in the Soonicorn category, has experienced major growth and, as the nominations read, that's to both Joe Alapat and Vincent Tran, co-founders, credit. The company has raised $12 million to date — the most recent round, a $10 million Series A — closed this year.

Houston-based SaaS company, Liongard, has closed its recent fundraising round led by one of HX Venture Fund's portfolio funds. Getty Images

Houston software startup closes $17M series B

money moves

A fast-growing software-as-a-service company has closed its latest round of funding to the tune of $17 million.

An information technology automation and management company, Liongard's round was led by Updata Partners with contribution by TDF Ventures, Integr8d Capital, and private investors. With customers in 20 countries, Liongard saw triple-digit customer growth and doubled its staff over the past 18 months, according to a news release.

Liongard's CEO, Joe Alapat, who co-founded the company with COO Vincent Tran in 2015, says that the new funds will continue to support its Roar platform — a software product that creates a single dashboard for all data systems and allows automation of managed service providers, or MSPs, for auditing and security within a company's IT.

"Since the launch of Liongard, the platform's adoption and popularity with MSPs has grown rapidly, transforming Liongard into a highly recognized brand in the MSP ecosystem," Alapat says in the release. "This new investment and the continued confidence of our investors will fuel our growth by giving us the means to further advance our solution's capabilities and serve our customers at an even better level."

Liongard's total funding now sits at over $20 million. Last year, the company raised a $4.5 million series A round following a $1.3 million seed round in 2018. TDF Ventures and Integr8d Capital have previously invested in the company.

Lead investor, Updata Partners, is based in Washington D.C. and invests in SaaS, tech-enabled service providers, and digital media and e-commerce. The HX Venture Fund, a fund-of-funds under Houston Exponential, has invested in Updata Partner's recent fund.

"Liongard has recognized an industry gap and addressed the need for greater visibility in how systems are managed," says Carter Griffin, a general partner at Updata Partners, in the release.

"The team created a valuable solution for MSPs, making the company an excellent investment opportunity for Updata. The combination of Liongard's in-demand platform, strong market presence, robust roadmap for ongoing growth and strong leadership team point to a company well-positioned for ongoing success."


Joe Alapat is the CEO of Houston-based Liongard. Courtesy of Liongard

Houston-based Liongard's Roar technology is helping its customers get all their IT services under one umbrella. Getty Images

Houston-based B2B tech company is connecting the dots on IT services

Hear me Roar

Houston-based startup Liongard, an Information Technology automation and management company, was founded on the idea that managing data and technology for companies shouldn't be so difficult.

Before founding Liongard, CEO Joe Alapat and COO Vincent Tran owned and operated Empact IT, an IT company, for more 10 years. In the decade they owned the company, Alapat said they saw the industry completely change as protecting a business' information and data became more challenging.

"[IT is] not all on one place in a data center anymore: it's in the Cloud, it's on the network, it's in app services and in on-premise [offices]," Alapat says. "The security problem is huge and that's exploding because … we lack visibility into basic things when we're managing IT. We just want to be able to manage it and get back to sanity."

After the duo sold the IT company in 2012, Alapat and Tran used the funds from the sale to launch Liongard in 2015 with the focus of automating the management of the plethora of systems that can overwhelm Managed Service Providers, or IT Service Providers.

"Everyone thinks their IT department is high-tech," Alapat says. "Unfortunately, the department that's supposed to be so high-tech is actually pretty manual. And they won't let on that it's challenging, but it really is [and] there's a lot of manual work involved."

So, Alapat and Tran developed Roar: a software product that creates a single dashboard for all data systems including the Cloud and apps, server networks, and on-site systems to make accessing and protecting the data easier. Alapat said Roar is able to inspect multiple systems and bring back rich information without logging into each different system.

Liongard joined entrepreneurial accelerator Station Houston — an association that helps place young businesses in front of investors — in June 2016 and gained access to its network of mentors, advisers, and investors.

In spring 2018, Liongard completed its Seed Stage round of its capital campaign with $1.3 million in investments. With these initial funds, Liongard was able to put Roar on the market in April 2018 and expand its client base — growing from two clients to now close to 200 customers in less than a year.

This year, the company will launch the second leg of its capital campaign with the goal of raising between $3 million to $4 million to help expand the company further.

Alapat said he thinks the company has been received well by Houston investors because Liongard offers a product that other IT management companies don't.

"No one has a unified way to look across the Cloud and network and apps and services and servers," Alapat

says. "There's plenty of different dashboards and solutions that looks at one or two of those things, but there's no single solution that consolidates all of that. That's what makes us different — that we unify all of that under one umbrella."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings